COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual? Brownlee WJ. Mult Scler 2020 Aug 7:1352458520948211. doi: 10.1177/1352458520948211.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brownlee WJ. COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual? Mult Scler 2020 Aug 7:1352458520948211. doi: 10.1177/1352458520948211.
PMID: 32762499